homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

May 22, 2018

Seattle Genetics

Bothell-based Seattle Genetics appointed Dr. Roger D. Dansey as chief medical officer. Dansey has experience developing cancer drugs, most recently at Merck where he was therapeutic area head for late stage oncology, working to register Keytruda for multiple tumor types. He succeeds Dr. Jonathan Drachman, who remains as strategic advisor for innovation.




Email or user name:
Password:
 
Forgot password? Click here.